Eight months in, 2024 is already a record year for M&A (mergers and acquisitions) in the investment trust sector.Trust boards are increasingly focused on value for money and shareholder returns amid persistently wide discounts to NAV (net asset value) and with activists nosing around. A major trend underway is mergers between sub-scale trusts with similar remits to create funds large and liquid en

RTW Biotech Opportunities (RTW) $1.11Loss to date: 16.5%We highlighted RTW Biotech Opportunities(RTW) at $1.33 in July for its superior trackrecord which was not reflected in the shares trading at an unwarranted 23% discount to NAV (net asset value).WHAT HAS HAPPENED SINCE WE SAID TO BUY?Sentiment in the biotechnology sector remains depressed with the Nasdaq Biotechnology index dropping around 6%

Since inception in October 2019 RTW Biotech Opportunities (RTW) has delivered 65.3% growth in NAV (net asset value), smashing the performance of the Russell 2000 Biotech index which is down 0.7% as well as the NBI (Nasdaq Biotech Index) which is up 20.6% over the same period.Despite the superior performance to the benchmark and peers, the shares trade at an unwarranted 23% discount to NAV, represe

With so much macroeconomic uncertainty, the recent mergers and acquisitions spree has lost momentum apart from one sector.Big pharmaceutical firms are awash with cash, yet patent cliffs (expiration of patent protection) present challenges which can be partially fixed by buying smaller biotech firms with products almost ready to go to market.International Biotechnology Trust's (IBT) Ailsa Craig and

Rising interest rates since the turn of the year, runaway inflation and Russia's shocking invasion of Ukraine have shaken the investment kaleidoscope in 2022 and forced many investors to reposition portfolios for an increasingly uncertain world.This is reflected in developments in the investment trusts universe, which has thrown up some obvious and more surprising winners in the opening months of

Joe Biden is now officially president of the United States, something which is likely to have implications for your portfolio.His policy plans, ranging from infrastructure and renewable energy to technology and healthcare, will have direct impact on indices like the S&P 500 and FTSE 100, as well as a lot of the big companies held in a wide range of high-profile funds.INFRASTRUCTURE STOCKSOne of Bi